Characterization of patients with type 1 diabetes mellitus in Southern Brazil: Chronic complications and associated factors

Revista da Associacao Medica Brasileira

Volumn 56, Issue 1, 2010, Pages 67-73

  Rodrigues, Ticiana C ^a   Pecis, Miriam ^b   Canani, Luis Henrique ^a   Schreiner, Luciana ^b   Kramer, Caroline K ^a   Biavatti, Karina ^a,c   Macedo, Bruno ^a,c   Esteves, Jorge F ^a   Azevedo, Mirela J ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c CNPq   (Brazil)

Author keywords

Diabetes complications; Diabetic angiopathies; Type 1 diabetes mellitus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; HOSPITALIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTOR;

ADOLESCENT; ADULT; AGED; BRAZIL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 77953449571     PISSN: 01044230     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-42302010000100019     Document Type: Article

References (35)

1. Halimi S, Benhamou PY. Diabetes, a worldwide disease. Presse Med. 2004;33:37-40.
2. Caramori ML, Gross JL, Pecis M, Azevedo MJ. Glomerular filtration rate, urinary albumin excretion rate, and blood pressure changes in normoalbuminuric normotensive type 1 diabetic patients: an 8-year follow-up study. Diabetes Care. 1999;22:1512-6.
3. Mourão CA, Sá JR, Guedes OM, Dib SA. Glycaemic control in adult type 1 diabetes patients from a brazilian country city: comparison between a multi- disciplinary and a routine endocrinological approach. Arq Bras Endocrinol Metab. 2006;50:944-50.
4. Sampaio E, Almeida HG, Delfino VD. Nephropathy and retinopathy in type 1 diabetics assisted by a universitary multiprofessional program. Arq Bras Endocrinol Metab. 2007;51:410-8.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
6. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321:412-9.
7. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complica- tions of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12.
8. Chaturvedi N, Fuller JH, Taskinen MR. Differing Associations of Lipid and Lipo- protein Disturbances with the Macrovascular and Microvascular Complications of Type 1 Diabetes. Diabetes Care. 2001;24:2071-7.
9. Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care. 2006;29:1220-6.
10. Knopp RH, dEmden M, Smilde JG, Pocock SJ. Efficacy and safety of atorv- astatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care. 2006;29:1478-85.
11. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HP, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348: 383-93.
12. Gæde P, Lund-AndersenH, Parving HH, Pendersen O. Effect of a Multifacto- rial Intervention on Mortality in Type 2 Diabetes. N Engl J Med. 2008;358: 580-91.
13. American Diabetes Association. Standarts of medical care in diabetes. Diabetes Care. 2008; 31(Suppl):s12-s54.
14. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, et al. American Diabetes Association; American College of Cardiology Foundation; American Heart Association. Intensive glycaemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol. 2009;53:298-304.
15. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, American Diabetes Association; European Association for Study of Diabetes. Medica Management of Hyperglycaemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193-203.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.
17. Arcanjo CL, Piccirillo LJ, Machado IV, Andrade Jr CRM, Clemente EL, Gomes MB. Avaliação de dislipidemia e de índices antropometricos em pacientes com diabetes mellitus tipo 1. Arq Bras Endocrinol Metab. 2005;49:951-8.
18. Rodrigues TC, Pecis M, Azevedo MJ, Esteves JF, Gross JL. Ambulatory Blood Pressure Monitoring and Progression of retinopathy in normotensive, normo- albuminuric type 1 diabetic patient: A 6 - year follow-up study. Diabetes Res Clin Pract. 2006;74:135-40.
19. Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677-82.
20. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney: evaluation, clas- sification, and stratification. Ann Intern Med. 2003;139:137-47.
21. nd ed. England: WHO; 1982. p. 123-65. [WHO Monograph Series.]
22. Paloheimo L, Pajari-Backas M, Pitkanen M et al. Evaluation of an Imunoturbi- dimetric Microalbuminuria Assay. J Clin Chem Biochem. 1987;25:889-92.
23. Bryden KS, Dunger DB, Mayou RA, Peveler RC, Neil HA: Poor prognosis of young adults with type 1 diabetes: a longitudinal study. Diabetes Care. 2003; 26:1052-7.
24. Lovestam-Adrian M, Agardh CD, Torffvit O, Agardh E. Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care. J Diabetes Complications. 2001; 15:287-94.
25. Porta M, Sjoelie A-K, Chatuverdi N, Stevens L, Rottiers R, Veglio M, et al. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia. 2001;44:2203-9.
26. Wolf G, Muller N, Mandecka A, Muller UA. Association of diabetic retinopathy and renal function in patients with types 1 and 2 diabetes mellitus. Clin Nephrol. 2007; 68:81-6.
27. Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet. 2003;361:2005-16.
28. Consensus development on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998. Miami, Florida: American Diabetes Association. Diabetes Care. 1998;21:1551-9.
29. Deckert T, Poulsen JE, Larsen M. Prognosis of diabetics with diabetes onset before the age of thirty-one. Factors influencing the prognosis. Diabetologia. 1978;14: 371-7.
30. Krolewski AS, Kosinski EJ, Warram JH. Magnitudeanddeterminantsofcoronary artery disease in juvenile-onset insulin-dependent diabetes. Am J Cardiol. 1987; 59:750-55.
31. Price CT, Becker DJ, Costacou T, Miller RG, Orchard TJ. Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia. 2007;50: 2280-88.
32. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Inten- sive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643-53.
33. De Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, et al. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Insulin therapy, hyperglycaemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med. 2008;168:1867-73.
34. Maahs DM, Hokanson J, Kinney GL, Ehrlich J, Wadwa P, Garg S, et al. Hypertension prevalence, awareness, treatment, and control in an adult type 1 diabetes population and a comparable general population. Diabetes Care. 2005;28:301-6.
35. Cobas R, Santos B, Braga L, Cunha EF, Gomes MB. Evolução para Hipertensão Arterial em Pacientes com Diabetes Tipo 1. Arq Bras Endocrinol Metab. 2008;52:628-34.